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Saira Saleem1*, Arif Jamshed2, Saima Faisal3, Raza Hussain4, Muhammad Tahseen5, Asif Loya5 and Chris Sutton6Abstract
Recently a sub-population of cells with stem cell characteristics, reported to be associated with initiation, growth,
spread and recurrence, has been identified in several solid tumors including oral tongue squamous cell carcinoma
(OTSCC). The aim of our pilot study was to isolate CD44+ cancer stem cells from primary cultures of OTSCC and
neck node Level I (node-I) biopsies, grow cell spheres and observe their characteristics in primary cultures. Parallel
cultures of hyperplastic lesions of tongue (non-cancer) were set up as a control. Immunohistochemistry was used
to detect CD44/CD24 expression and magnetic activated cell sorting to isolate CD44+ cell populations followed by
primary cell culturing. Both OTSCC and node-I biopsies produced floating spheres in suspension, however those
grown in hyperplastic and node-I primary cultures did not exhibit self-renewal properties. Lymph node metastatic
OTSCC, express higher CD44/CD24 levels, produce cancer cell spheres in larger number and rapidly (24 hours)
compared to node negative OTSCC (1 week) and non-cancer specimens (3 weeks). In addition, metastatic OTSCC
have the capacity for proliferation for up to three generations in primary culture. This in vitro system will be used to
study cancer stem cell behavior, therapeutic drug screening and optimization of radiation dose for elimination of
resistant cancer cells.
Keywords: Oral tongue squamous cell carcinoma, Lymph node metastasis, Primary culture, Cancer cell sphere,
Cancer stem cells, in vitro assayIntroduction
The incidence of head and neck squamous cell carcinoma
(HNSCC) varies worldwide but is more prevalent in South
Asia [1,2]. In Pakistan, the factors contributing to in-
creased incidence in oral cancer were life style habits of
smoking, betel quid chewing, and other addictive sub-
stances [3]. For all age groups and both genders, lip and
oral cavity malignancies were the third most prevalent
(5.88% of the 63,881 cases registered from 1994–2013 -
www.shaukatkhanum.org.pk). The commonly observed
presence of neck lymph node metastasis (LNM) in oral
squamous cell carcinoma (OSCC) patients signifies the
regional spread of the disease. Despite various treatment
options for OSCC, the survival rates are poor, which is in* Correspondence: sairas@skm.org.pk
1Basic Sciences Research Department, Shaukat Khanum Memorial Cancer
Hospital and Research Center, 7-A Block R-3, Johar Town, Lahore, 54000,
Pakistan
Full list of author information is available at the end of the article
© 2014 Saleem et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.part attributed to the limited understanding of the re-
sistant cancer cells which are now termed cancer stem
cells (CSCs) or tumor initiating cells (TICs).
The hypothesis that only a sub-fraction of cells within a
tumor, sharing stem-like characteristics, can regenerate the
heterogeneous tumor, promote metastasis and recurrence,
is gaining importance and is termed cancer stem cell theory
[4]. The first evidence for the existence of CSCs was
reported in blood borne cancer based on expression
of CD34+CD38- markers [5]. This was followed by their
identification in solid tumor cancers including breast
(CD44+CD24-) [6,7], brain (CD133+) [8], prostate (CD44+)
[9] and pancreatic tumor (CD44 + CD24 + ESA+) [10].
Identification of CD44+ head and neck cancer stem cells
(HNCSC) is a relatively recent discovery following isolation
from a mouse xenograft model of HNSCC [11]. Clonogenic
assays produce a gradient of change in morphology and
compactness of cells constituting different colonies, namely
holoclones, meroclones and paraclones consisting of tightly,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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used to evaluate CSC properties [12]. Immortalised cell
lines, however, will have acquired cellular and phenotypic
changes and may not accurately represent molecular and
cellular events occurring in in vivo tumors. In the present
study, we used primary cell sources isolated from human
tongue tissue biopsies to study CSC properties.
Materials and methods
All chemicals obtained from Sigma unless specified
otherwise.
Patient selection
Ethical approval of the study was obtained from the
Internal Review Board on Human Research at Shaukat
Khanum Memorial Cancer Hospital and Research Center
(SKMCH&RC), Pakistan. A total of 8 clinical tissue
specimens were obtained after getting consent from
patients undergoing surgery during the year 2013.
Partial glossectomy was performed to collect five primary
tongue tumors and three hyperplastic growths on tongue
as non-cancer controls. Where there was unilateral neck
dissection or bilateral modified radical neck dissection
undertaken alongside glossectomy, five node-I specimens
were collected. Freshly resected specimens were acquired
by a pathologist and 3mm3 of biopsy collected in RMPI
medium with 5× antibiotic for cell culture and isolation of
cells. Remaining tissue was immediately preserved either by
fixing in formalin for embedding into paraffin wax (for
histopathological diagnosis) or stored at −80°C in 1×PBS
(phosphate-buffered saline). The presence of hyperplastic
or neoplastic cells in the acquired specimen was confirmed
by two clinical pathologists. The clinical and pathological
characteristics of patients are summarized in Table 1.
Immunohistochemistry
Sections (4 μm) were de-paraffinized in xylene, rehydrated
for CD44 and CD24 detection. The sections were treated
with hydrogen peroxide (H2O2; 3% 10 min) at room
temperature (RT), washed in distilled water (DW), treated
with microwave heating for 15 min in a citrate buffer (pH
9.0) for antigen retrieval, washed in DW and treated with
PBS for 5 min. Non-specific binding was blocked by in-
cubation with blocking reagent (Dako) for 5 min at RT, in
a wet chamber. Incubation with a monoclonal antibody
against all human CD44 isoforms (1:50 dilution, R&D
Systems) or all CD24 isoforms (1:1000 dilution, R&D
Systems) was carried out for 35 min at 37°C. The immuno-
reactivity was detected using the Dako Envision kit with
peroxidase activity using 3, 3’-diaminobenzidine (DAB) as
substrate. Finally, the sections were counterstained with a
hematoxylin, dehydrated, cleared in xylene and mounted
with Eukitt (DeltaLab). Immunohistochemistry negative
controls were prepared by omitting the primary antibody.Tumor sphere culturing
Each biopsy was proteolytically digested to generate
single-cell suspensions. Briefly, specimens were cut into
small fragments, minced with a sterile scalpel, and
immersed in Dulbecco’s Modified eagles Medium (DMEM)
containing 40 Units Dispase II /mL. The combination was
incubated at 37°C for up to 3 hours and with mixing every
15 minutes to enable complete digestion. The resulting
single-cell suspension was filtered through 40 μm nylon
mesh and washed twice with HBSS/2% HICS (Hank’s
buffered salt solution in heat inactivated calf serum).
Primary cultures for each type of fresh specimen
(OTSCC tumor, hyperplastic and neck node) were set
up separately by the method of Harper et al. without
the use of feeder cells [13]. Briefly, specimens were
collected in RM+ [consisting of a 3:1 ratio of DMEM:
F12 with 10% fetal bovine serum (FBS), 1% glutamine,
0.4 μg hydrocortisone, transferrin 5 μg⁄mL, insulin 5 μg⁄mL,
EGF 10 ng⁄mL, 1× antibiotic⁄antimycotic mixture] and incu-
bated overnight at 4°C. The samples were washed (3×) in
fresh RM+ medium with vortexing to remove any debris.
Approximately 1mm2 pieces were placed in culture flask
coated with thin layer of autoclaved 0.1% agarose or agar.
This was followed by addition of RM+ medium and culture
flasks were placed in a humid incubator at 37°C and 5%
CO2 with the medium changed once per week. When out-
growing cells approached confluence and floating spheres
were formed, they were collected by centrifugation.
Magnetic bead affinity cell sorting (MACS) of CD44+ and
CD44- cells
Collected spheres from OTSCC tumor, hyperplastic
and neck node cultures were dissociated with 40 Units
Dispase II /mL of DMEM incubation and vortexed for 15
minutes to form single-cell suspension. Following, filtering
and washing, a MagCellect™ cell isolation kit (R&D
Systems) was used to isolate CD44+ and CD44- cells
from each as per the manufacturer’s instructions.
CD44+ and CD44- cell culture
Isolated CD44+ and CD44- cells were cultured without
feeder cells (fibroblasts or amniotic membrane) in RM+
medium to test their ability for forming spheres potentially
harboring CSCs. The cells were passed through a 40 μm
filter, and 10 mL of medium containing 2 × 104 cells was
added to 25 mm2 culture flasks coated with 0.1% agarose
or agar. After 1–2 weeks culture flasks were visually
assayed for the formation of floating spheres.
Stem cellness self-renewal assay
The spheres were collected by centrifugation and
digested to single-cell suspensions using Dispase II
(20U/mL of DMEM). After passing through a 40 μm
filter, 250 cells/cm2 cells in 10 mL of medium was added
Table 1 Characteristics of study subjects with tongue cancer or hyperplasia
Patient Gender Age Tobacco use Alcohol use Betel nut use Primary tumorsite Histologic grading
T
classification
Lymph node
involvement
Distant
metastasis
Prior
radiation
Prior
chemo
1 F 60 No No No Tongue Hyperplasia pT0 pN0 M0 No No
2 M 60 No No No Tongue ND pTx pN1a M0 No No
3 F 55 No No
1-2 times a day. Started
at the age of 18. Quit
since past 5 months.
Tongue G2 pT2 pN0 M0 No No
4 M 49
ocassional smoking.
Started at the age of
20. Quit for the past
8 months.
No
3-4 times a day. Started
at the age of 16. Quit
since past 8 months.
Tongue G1 pT1 pN0 M0 Yes
Cisplatin +
Gemcitabine 2x
5 F 26 No No
1 sachet/day. Started
at the age of 6. Quit
since past one year.
Tongue G2 pT2 pN0 M0 No No
6 M 46 No No No Tongue Hyperplasia pT0 Not resected M0 No No
7 M 25 No No No Tongue G2 pT1 pN0 M0 No
Cisplatin +
Gemcitabine 2x
8 F 56
2-3 cigrettes/day.
Started at the age
of 7. Still somkes.
No No Tongue Hyperplasia pT0 Not resected M0 No No
p: pathologic.
T0: No evidence of tumor.
T1: Tumor 2cm or less in greatest dimension.
T2: Tumor more than 2cm but not more than 4cm in greatest dimension.
ND: Not detected.
N0: No regional lymph node metastasis.
N1a: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension.
M0: No evidence of distant metastasis.
G1: Well differentiated.
G2: Moderately differentiated.
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flasks for daughter sphere formation and colony forma-
tion, respectively. The floating spheres and colonies were
observed using phase contrast microscope (Labomed
TCM 400). The viability of the cells was also confirmed by
Trypan blue exclusion method.
Results
CD44/CD24 expression and sphere formation in primary
cultures of tongue and node biopsies
Immunohistochemistry of tissue sections indicated in-
creased CD44 expression (Figure 1a-c) through hyperplastic
to neck node negative and neck node positive OTSCC. The
cells in the basal layer expressing CD44 (Figure 1d-f) were
negative for CD24 (Figure 1g-i) suggesting differential
expression. The biopsies from hyperplastic, non-metastatic
(neck node negative) and metastatic (neck node positive)
OTSCC were incubated in conditioned media to observeFigure 1 Tumor grading and expression of CD44 and CD24 in selecte
grading of tongue lesion or tumors. Middle panel (d-f): CD44 staining. Low
CD44 (black arrows) are negative for CD24 (black arrows). Magnification 40their sphere formation patterns in primary cell culture
(Table 2). The proliferation of cells was slowest in
hyperplastic cells (Figure 2a), faster in non-metastatic
OTSCC (Figure 2b) and fastest in lymph node metastatic
OTSCC (Figure 2e), with pathologically negative and posi-
tive node-I (Figure 2d and g) tissues generating floating
spheres within 24 hours (Figure 2c and f).
CD44+ cells primary culture
Purified CD44+ cells exhibited much higher sphere-
forming abilities than the CD44- counterparts. The floating
cancer cell spheres were generated within 1 week from
CD44+ cells (Figure 3A,a), whereas CD44- cells started
to differentiate by 3rd day of the culture (Figure 3A, b).
The cells isolated from hyperplastic or non-cancer tissue
did not produce characteristic spheres. Node-I tissue
formed clusters of cells and did not produce typical sphere
contours (Figure 3A, c and d).d tongue tissues. Top panel (a-c): H&E staining for diagnosis and
er panel (g-i): CD24 staining. The cells in the basal layer expressing
x.
Table 2 Number and size of spheres or spheroids in primary cultures and MACS isolated CD44+ cell cultures
Primary cell spheres CD44+ cell spheres
Tissue type Parentspheres
Passage
1
Passage
2
Passage
3
Parent
spheres
Passage
1
Passage
2
Passage
3
Passage
4
H Duration NumberCells/sphere
3 weeks
None None None Cluster of cells 10-15 None None None None15-20
10-30
OTSCC
(Neck Node -)
Duration Number
Cells/sphere
1 week 1 week 1 week
None
1 week 1 week 1 week 1 week
None30-40 15-20 10-15 20-30 20-30 10-15 Up to 10
20-50 10-25 up to 10 15-25 10-15 up to 10 3-5
OTSCC
(Neck Node+)
Duration Number
Cells/sphere
1 day 1 day 1 day 1 day 1 day 1 day 1 day 1 day
None40-50 30-40 15-20 10-15 30-40 30-40 15-25 Up to 10
50-100 50-100 20-50 Up to 10 20-30 15-25 10-15 3-5
Cells plated at a density of 250/cm2 in 10mL of conditioned media in 0.1% agarose or agar coated non-adhesive culture flasks. Triplicate analyses were done from
each sample type.
Figure 2 Representative phase contrast images of spheres (black arrows) formed in suspension in primary cultures of OTSCC (a,b,e)
and neck nodes (c,f) in growth factor supplemented medium in non-adhesive 0.1% agarose coated plastic ware and H&E staining of
neck nodes (d,g). (a) created and survived for 3 weeks. Daughter spheres were not formed. (b) created within 1 week, survived for 3 weeks.
Re-passaged for 2 generations. (c) spheres formed in primary cultures of negative neck nodes within 24hours. Daughter spheres were not formed.
(d) H&E staining of negative neck node (e) spheres created within 24 hours and survived for several weeks. Re-passaged for 3 generations. (f)
spheres formed in primary cultures of positive neck nodes within 24hours. Daughter spheres were not formed. (g) H&E staining of positive neck
node. Red arrow pointing to malignant cells. Magnification 40x.
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Figure 3 Sphere formation by CD44+ cells isolated from tongue and neck node tissues. A: CD44+ cells from tumor and neck node tissue
(Magnetic activated bead isolation followed by cell culture in conditioned media in non-adhesive 0.1% agarose coated plastic ware. (a) The
proliferating CD44+ cells from OTSCC (lymph node metastatic and non-metastatic) formed spheres or spheroids (b) CD44- cells differentiated
during 1 week (c) CD44+ cells isolated from neck nodes (Level I) (d) CD44- cells from neck nodes (Level I) B: Clonogenic assay for self-renewal.
Purified CD44+ cells were plated at 250cells/mm2 and cultured for 1 week. (a) holoclone comprising of compact cells (b) meroclone containing
loosely arranged cells on adhesive plastic ware (c) paraclone comprising of sparsely arranged cells on adhesive plastic ware (d) No colonies were
formed in nodes secondary cultures. No cell spheres were formed from non-cancer tissues (not shown). Magnification 40x.
Saleem et al. Cancer Cell International  (2014) 14:542 Page 6 of 8Self-renewal of cancer cell spheres
The abilities for self-renewal and adoption of a spherical
morphology, attributed to the presence of CSCs, were
tested by collecting the CD44+ cell spheres and culturing
them after dissociation into single-cells. The secondary
spheres were formed within 1 week from OTSCC samples
while small spheres from hyperplastic tissue did not
regenerate secondary spheres. Secondary spheres, with
typical meroclones and paraclones features, were formed
by the third day from non-metastatic and metastatic
OTSCC (Figure 3B, a-c), but in notably different numbers
10–15 vs. 15–25, respectively (Table 2). A progressive loss
of regenerative ability by the third passage was observed
with primary cells from all sources.
Discussion and conclusion
We established primary cultures from human OTSCC and
matched neck nodes Level I, to grow cancer cell spheres,
isolated CD44+ cells by MACS followed by culturing to
produce CD44+ cell spheres. Moreover, in agreement
with the published work [12], spheres in suspension and
adherent holoclones, meroclone and paraclone wereobserved. Epithelial stem cells of endodermal origin
have been isolated from mouse tongue previously and
their cultures produce self-renewable holoclones [14].
The retention of intrinsic properties restricted to specific
sub-population could be used to create a long-lasting
response to treatment and prolonged disease free survival
by elimination of these by targeted therapy [15].
The cells isolated from hyperplastic or non-cancer tissue
did not produce characteristic spheres confirming the
hypothesis that only tumor cells have the sub-population
of sphere forming cells retain self-renewal abilities. The
spheres were created and survived over different time
periods (1–21 days), which could be attributed to the
different type of cells in various tissues. From the difference
in patterns of sphere formation from hyperplastic and
carcinoma specimen in cell culture, it is evident that
every tumor is individual at cellular level stressing the
need for personalized medicine.
CD44 plays various roles from adhesion to signaling
[16], and is also known as a marker of tumor aggressive-
ness playing a functional role in metastasis [17] and a
promising marker of CSCs [18]. CD24 is a known marker
Saleem et al. Cancer Cell International  (2014) 14:542 Page 7 of 8of differentiation [6] and plays role in B-cell interactions
[19]. As observed in this study, the detection of CD44 in
the basal-like cell layer, containing tumorigenic population
of cancer cells, has been reported in primary head and
neck squamous cell cancer specimen [20].
In the present study, the idea was that if some CSCs
get trapped in the neck nodes, these will generate the
similar spheres in culture as formed in case of tongue
tumors. Since neck nodes can be available in large
amounts and are more proliferative so would be an ideal
in vitro system for future studies on CSCs in primary
culture. In node, however, only small cell clusters were
formed in CD44+ cells cultures (Figure 3A, c) possibly
because of low number of these cells or competing
markers on various cells for CD44 + ve magnetic beads.
We observed that sphere formation is correlated with
the nodal involvement of cancer because pathologically
node positive OTSCC produced cell spheres in large
numbers correlating with worse prognosis. Comparative
account of these spheres in various stages of cancer can
be studied giving clues regarding progress of disease
and metastasis. In head and neck cancer, lymph node
metastasis has been linked with poor prognosis and
distant metastasis [21]. In order to metastasize, cancer
cells must first detach from the primary tumor and
invade blood vessels or lymphatics either by a passive
process where cells are simply sloughed off from the
primary tumor or an active one involving directed
migration [22]. While some gene expression studies
have suggested that distant metastases resemble their
primary tumors of origin [23] other studies have indicated
that the expression of specific genes is altered in metastatic
cells [24]. It can be assumed that the altered expression of
a limited number of genes may render a sub-population of
cells fully competent for metastasis, without changing its
overall similarity with the primary tumor. A rise in number
of circulating CSCs would correlate with the possibility of
metastasis. There is an urgent need for information on the
possible molecular mechanisms mediating the self-renewal
of CSCs by their characterization at the genetic and
proteomic level. Comparison of normal and cancer
stem cells may provide a starting point for identifying
proteins responsible for driving these mechanisms.
The results of this preliminary study provide the means
for generating CSCs that we will use for in-depth
‘omics analysis.
In summary, we successfully generated cancer cell
spheres in primary cultures of OTSCC and neck nodes
Level I. The formation of similar cell spheres in node
primary cultures as found in OTSCC cultures may offer
an opportunity to use this in vitro system to characterize
CSCs since neck nodes can be available in large amounts
and are highly proliferative. We also isolated CD44+ cells
from cancer cell spheres by magnetic beads and culturedin supplemented medium producing CD44+ cell spheres.
The potential applications for tongue and nodal
CSCs characterization include monitoring of CSCs as
biomarkers of acquired resistance to new cancer therapies,
identifying new potential therapeutic targets to directly
suppress cancer metastasis and develop high-throughput
technologies for CSC detection applying these at earlier
stages of cancer progression with the goal of early cancer
detection.
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